All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...795Next →

hiv & aids news selected from other sources

  • Drug-resistant TB
    TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool
    Yahoo Finance | 24 March 2017

    On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to the development of sutezolid in combination with other TB drugs and follows the MPP's license for the treatment signed with patent holder The Johns Hopkins University in January.

  • Drug-resistant TB
    New Tuberculosis Drugs May Become Ineffective: Study
    Inter Press Service | 24 March 2017

    New antibiotics that could treat tuberculosis may rapidly become ineffective, according to new research published by the Lancet ahead of World Tuberculosis Day. The rise in multi-drug resistant tuberculosis, which affected 480,000 people in 2015, could mean that even newly discovered drugs will soon be useless, the study found.

  • PrEP
    Trialling PrEP: What happened to the NHS PrEP trial?
    Boyz | 23 March 2017

    When NHS England announced at the start of December 2016 that they’d be funding a new large-scale PrEP trial, many people thought that they’d be able to access PrEP in the spring. More than 3 months later, and the trial has not even started to recruit. Dr Will Nutland from gives an update about what’s going on with the trial.

  • Starting treatment
    Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?
    ITPC | 23 March 2017

    Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

  • History of HIV and AIDS
    An interview with Gordon Scott: part 2
    HIV Scotland | 23 March 2017

    Gordon Scott worked in HIV medicine for 35 years latterly as Clinical Director and GUM Consultant, NHS Lothian Sexual and Reproductive Health. He retired in 2016. To mark his retirement we spent some time asking him about his experience. In the second of a two part interview he talks about the early days of working in the field and developments made in treatment at that time.

  • Finance and funding
    Why Trump’s N.I.H. Cuts Should Worry Us
    New York Times | 23 March 2017

    A substantial N.I.H. budget cut would undermine the fiscal stability of universities and medical schools, many of which depend on N.I.H. funding; it would erode America’s leadership in medical research; and it would diminish opportunities to discover new ways to prevent and treat diseases.

  • TB treatment
    WHO issues ethics guidance to protect rights of TB patients
    World Health Organization | 23 March 2017

    New tuberculosis (TB) ethics guidance, launched today by the World Health Organization (WHO), aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected.

  • Achieving the 90-90-90 target
    Zim on course to meet UN target to end HIV, Aids
    NewsDay | 23 March 2017

    ZIMBABWE is on course to meeting the United Nations’ 90-90-90 ambitious target to help end the HIV and Aids pandemic by 90% in 2020, a Zimbabwe Population Based HIV Impact Assessment (Zimpha) survey says.

  • TB treatment
    Health alert: India has 25% of the world's tuberculosis patients
    Hindustan Times | 23 March 2017

    Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

  • Drug-resistant TB
    Rise of superbug tuberculosis hampers global control efforts
    Reuters | 23 March 2017

    Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

← First12345...1295Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.